Latest Articles

Cryo electron microscopy (cryo EM) has revolutionized our understanding of the intricate molecular machinery that governs life. In this article, we discuss what cryo EM is, how it works, it's strengths, limitations and applications.

The next 10 years will likely bring gene editing to market for an array of rare conditions. However, making the potential benefits broadly available won’t be without roadblocks. Here, we explore some of the issues the industry will have to contend with.

This article will discuss how cell models are enabling researchers to elucidate the underlying biological mechanisms of disease to support diagnostic and therapeutic development.

Featuring expert academic insights, this article will outline recent research advancements in synthetic biology, including novel methods and applications.

This article will discuss progress on the development of the Immune Cell Atlas, the different techniques and technologies contributing to its development and some of the interesting findings that are coming out of the project.

In May, news broke of the first UK baby to be born through a new type of IVF procedure, called mitochondrial replacement therapy (MRT). We speak to a mitochondria expert to learn more about the procedure and why it is ethically "controversial".

In this article, we take a deep dive into the world of epigenetic aging clocks, finding out what they are, what they can tell us and how they might be applied in future.

This article will review the latest advances in next-generation sequencing technologies, data analysis tools and their various applications with key research examples.

In this opinion piece, Neil Ward discusses how the passing of the Genetic Technology "Precision Breeding" Bill could support global efforts to increase food production sustainably.

A new metabolomics workflow has been developed that combines state-of-the-art analytical instrumentation, which generates information-rich data, with a novel machine learning-based algorithm tailored to process it.